Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024William G. Wierda, Mary A. Dwyer, Jennifer R. Brown et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 83
COVID-19 in patients with CLL: improved survival outcomes and update on management strategiesLindsey E. Roeker, Sigrid S. Skånland, José‐Ángel Hernández‐Rivas et al.|Blood|2021Cited by 70
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimenMeghan C. Thompson, Anthony R. Mato, Rosemary Harrup et al.|Blood Advances|2022Cited by 57
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: “What's Past Is Prologue” (Shakespeare)Anthony R. Mato, Jennifer A. Woyach, Matthew S. Davids et al.|Clinical Cancer Research|2021Cited by 21
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLLJacob D. Soumerai, Deborah M. Stephens, Jacqueline C. Barrientos et al.|Blood Advances|2024Cited by 19